PADI4 and rheumatoid arthritis: Next, the activity of the 50 μM inhibitory compounds on GST-PAD4 in the presence of serum of healthy donors, as well as the serum and synovial fluid of patients with RA, all diluted 1:3 in the assay buffer, was examined.